GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PetMed Express Inc (NAS:PETS) » Definitions » Piotroski F-Score

PETS (PetMed Express) Piotroski F-Score : 4 (As of Dec. 11, 2024)


View and export this data going back to 1997. Start your Free Trial

What is PetMed Express Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

PetMed Express has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for PetMed Express's Piotroski F-Score or its related term are showing as below:

PETS' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 5   Max: 7
Current: 4

During the past 13 years, the highest Piotroski F-Score of PetMed Express was 7. The lowest was 1. And the median was 5.


PetMed Express Piotroski F-Score Historical Data

The historical data trend for PetMed Express's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PetMed Express Piotroski F-Score Chart

PetMed Express Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 5.00 4.00 4.00 4.00

PetMed Express Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 4.00 4.00 1.00 4.00

Competitive Comparison of PetMed Express's Piotroski F-Score

For the Pharmaceutical Retailers subindustry, PetMed Express's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PetMed Express's Piotroski F-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PetMed Express's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where PetMed Express's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Net Income was -2.027 + -5.016 + 3.754 + 2.326 = $-1.0 Mil.
Cash Flow from Operations was -2.593 + 7.125 + -8.517 + 7.389 = $3.4 Mil.
Revenue was 65.317 + 66.504 + 67.952 + 59.57 = $259.3 Mil.
Gross Profit was 17.883 + 18.177 + 17.971 + 17.311 = $71.3 Mil.
Average Total Assets from the begining of this year (Sep23)
to the end of this year (Sep24) was
(159.271 + 173.35 + 169.884 + 152.714 + 146.034) / 5 = $160.2506 Mil.
Total Assets at the begining of this year (Sep23) was $159.3 Mil.
Long-Term Debt & Capital Lease Obligation was $0.8 Mil.
Total Current Assets was $70.8 Mil.
Total Current Liabilities was $48.8 Mil.
Net Income was -0.212 + -0.216 + -1.136 + 0.715 = $-0.8 Mil.

Revenue was 58.87 + 62.407 + 78.244 + 70.999 = $270.5 Mil.
Gross Profit was 15.238 + 17.382 + 22.526 + 20.062 = $75.2 Mil.
Average Total Assets from the begining of last year (Sep22)
to the end of last year (Sep23) was
(169.265 + 165.121 + 167.478 + 180.737 + 159.271) / 5 = $168.3744 Mil.
Total Assets at the begining of last year (Sep22) was $169.3 Mil.
Long-Term Debt & Capital Lease Obligation was $1.1 Mil.
Total Current Assets was $85.7 Mil.
Total Current Liabilities was $40.7 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

PetMed Express's current Net Income (TTM) was -1.0. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

PetMed Express's current Cash Flow from Operations (TTM) was 3.4. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep23)
=-0.963/159.271
=-0.0060463

ROA (Last Year)=Net Income/Total Assets (Sep22)
=-0.849/169.265
=-0.0050158

PetMed Express's return on assets of this year was -0.0060463. PetMed Express's return on assets of last year was -0.0050158. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

PetMed Express's current Net Income (TTM) was -1.0. PetMed Express's current Cash Flow from Operations (TTM) was 3.4. ==> 3.4 > -1.0 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep23 to Sep24
=0.768/160.2506
=0.00479249

Gearing (Last Year: Sep23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep22 to Sep23
=1.08/168.3744
=0.00641428

PetMed Express's gearing of this year was 0.00479249. PetMed Express's gearing of last year was 0.00641428. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep24)=Total Current Assets/Total Current Liabilities
=70.779/48.832
=1.44943889

Current Ratio (Last Year: Sep23)=Total Current Assets/Total Current Liabilities
=85.66/40.695
=2.1049269

PetMed Express's current ratio of this year was 1.44943889. PetMed Express's current ratio of last year was 2.1049269. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

PetMed Express's number of shares in issue this year was 20.939. PetMed Express's number of shares in issue last year was 20.78. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=71.342/259.343
=0.27508743

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=75.208/270.52
=0.27801272

PetMed Express's gross margin of this year was 0.27508743. PetMed Express's gross margin of last year was 0.27801272. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep23)
=259.343/159.271
=1.62831275

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep22)
=270.52/169.265
=1.598204

PetMed Express's asset turnover of this year was 1.62831275. PetMed Express's asset turnover of last year was 1.598204. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+1+0+0+0+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

PetMed Express has an F-score of 4 indicating the company's financial situation is typical for a stable company.

PetMed Express  (NAS:PETS) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


PetMed Express Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of PetMed Express's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


PetMed Express Business Description

Traded in Other Exchanges
Address
420 South Congress Avenue, Suite 100, Delray Beach, FL, USA, 33445
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
Executives
Jacqueline Paula Smith other: Vice President of People 420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445
Gian Fulgoni director
Christine Chambers officer: CFO 1501 1ST AVENUE SOUTH, STE. 600, SEATTLE WA 98134
Mathew N Hulett director, officer: CEO & President 1621 NORTH KENT STREET, SUITE 1200, ARLINGTON VA 22209
Campbell Leslie C.g. director C/O COUPA SOFTWARE INC., 1855 S. GRANT STREET, SAN MATEO CA 94402
Diana G Purcel director C/O FAMOUS DVES OF AMERICA INC, 8091 WALLACE ROAD, EDEN PRAIRIE MN 55344
Moseley Mark Bradley Jr other: Chief Technology Info Officer 420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445
Daniel Job Pingree other: Chief Marketing Officer 420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445
Sandra Yvette Campos director 4900 E DUBLIN GRANVILLE RD, COLUMBUS OH 43081
Carolyn Carden other: VP of Product 420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445
Peter Cobb director DSW, INC., 810 DSW DRIVE, COLUMBUS OH 43219
Jodi Watson director 420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445
Frank J Formica director 1441 S.W. 29TH AVENUE, POMPANO BEACH FL 33069
Bruce S Rosenbloom officer: Chief Financial Officer 6401 CONGRESS AVENUE, SUITE 250, BOCA RATON FL 33487
Menderes Akdag director, officer: Chief Executive Officer 1441 S.W. 29TH AVENUE, POMPANO BEACH FL 33069